| Literature DB >> 24596458 |
Assumpta Ferrer1, Francesc Formiga2, Héctor Sanz3, Oscar J de Vries4, Teresa Badia5, Ramón Pujol2.
Abstract
BACKGROUND: The purpose of this study was to assess the effectiveness of a multifactorial intervention to reduce falls among the oldest-old people, including individuals with cognitive impairment or comorbidities.Entities:
Keywords: elderly; falls; intervention
Mesh:
Year: 2014 PMID: 24596458 PMCID: PMC3940644 DOI: 10.2147/CIA.S57580
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
Figure 1Flow chart of participants throughout the trial.
Baseline characteristics of study subjects
| Characteristics | Control | Intervention | |
|---|---|---|---|
| Sex: female, n (%) | 101 (61.6%) | 101 (61.6%) | 0.91 |
| Widowed marital status, n (%) | 85 (51.8%) | 89 (54.3%) | 0.38 |
| Formal education >6 years, n (%) | 31 (18.9%) | 31 (18.9%) | 0.83 |
| Lives alone | 50 (30.5%) | 50 (30.5%) | 0.91 |
| Home hazards | 94 (57.3%) | 114 (69.5%) | 0.03 |
| Visual acuity, median (IQR) | 5.00 (3.0–10.0) | 5.00 (3.0–10.0) | 0.33 |
| Impaired auditory acuity, n (%) | 58 (35.4%) | 66 (40.2%) | 0.42 |
| Hypertension, n (%) | 128 (78.0%) | 121 (73.8%) | 0.44 |
| Diabetes mellitus, n (%) | 26 (15.9%) | 30 (18.3%) | 0.66 |
| Dyslipidemia, n (%) | 84 (51.2%) | 84 (51.2%) | 0.91 |
| Ischemic cardiomyopathy, n (%) | 6 (3.7%) | 14 (8.5%) | 0.11 |
| Heart failure, n (%) | 21 (12.8%) | 21 (12.8%) | 0.87 |
| Previous stroke, n (%) | 19 (11.6%) | 30 (18.3%) | 0.12 |
| Dementia, n (%) | 17 (10.4%) | 14 (8.5%) | 0.71 |
| Anemia, n (%) | 36 (22.0%) | 20 (12.2%) | 0.03 |
| Parkinson’s disease, n (%) | 8 (4.9%) | 5 (3.1%) | 0.57 |
| Atrial fibrillation, n (%) | 22 (13.4%) | 19 (11.6%) | 0.74 |
| Charlson Comorbidity Index (0–37), median (IQR) | 1.00 (0.0–2.0) | 1.00 (0.0–2.0) | 0.55 |
| Number of drugs taken, median (IQR) | 6.00 (4.0–8.0) | 6.00 (4.0–8.0) | 0.50 |
| MNA, median (IQR) | 25.0 (22.5–27.5) | 25.5 (23.0–27.5) | 0.33 |
| Barthel Index | 95.0 (80.0–100) | 95.0 (85.0–100) | 0.50 |
| Tinetti test (0–9), median (IQR) | 8.00 (5.00–9.00) | 8.00 (5.00–9.00) | 0.56 |
| MEC | 28.0 (22.0–31.0) | 29.0 (23.8–32.0) | 0.16 |
| Falls in previous year, n (%) | 0.47 | ||
| 0 | 120 (73.2%) | 115 (70.1%) | |
| 1 | 32 (19.5%) | 36 (22.0%) | |
| 2 | 9 (5.5%) | 6 (3.7%) | |
| ≥3 | 3 (1.8%) | 7 (4.3%) | |
| HbA1C (%), median (IQR) | 5.65 (4.9–6.7) | 6.05 (5.2–7.0) | 0.24 |
| Total cholesterol (mmol/L), mean (SD) | 5.02 (1.0) | 5.04 (1.0) | 0.88 |
| HDL-c (mmol/L), mean (SD) | 1.47 (0.4) | 1.45 (0.4) | 0.66 |
| Albumin (g/L), mean (SD) | 41.2 (3.9) | 41.5 (3.8) | 0.55 |
| Calcium (mmol/L), mean (SD) | 2.32 (0.1) | 2.31 (0.1) | 0.32 |
| Home care, n (%) | 21 (12.8%) | 18 (11.1%) | 0.76 |
| Follow-up (days), median (IQR) | 744 (649–771) | 752 (706–774) | 0.11 |
Notes:
Impaired Jaeger score <5;
MEC: Spanish version of the Mini-Mental State Examination (cognitive impairment, 24/35);
Barthel Index, functional status (dependency <90); Tinetti test, 0–9;
albumin (normal range 37.0–53.0 g/L);
calcium (normal range 2.2–2.5 mmol/L).
Abbreviations: IQR, interquartile range; SD, standard deviation; MNA, Mini Nutritional Assessment questionnaire (nutritional risk <23.5); HbA1C, glucose hemoglobin; HDL-c, high-density lipoprotein cholesterol.
Figure 2Comparison of Kaplan–Meier survival curves for time to first and second fall between control and intervention group over 2 years of follow-up.
Cox models for time to first fall and for recurrent falls (control or intervention group)*
| First fall
| Recurrent falls
| |||||
|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | |
| Intervention group | 1.35 (0.91–2.02) | 1.41 (0.94–2.10) | 1.40 (0.93–2.10) | 1.42 (1.00–2.02) | 1.46 (1.03–2.08) | 1.46 (1.03–2.09) |
| Previous falls | – | – | 1.24 (0.81–1.90) | – | – | 1.09 (0.74–1.60) |
| Disability | – | 1.53 (1.01–2.33) | 1.41 (0.90–2.19) | – | 1.48 (1.02–2.13) | 1.44 (0.97–2.12) |
| Female | – | – | 1.27 (0.82–1.98) | – | – | 1.18 (0.80–1.75) |
| Cognitive impairment | – | – | 1.16 (0.74–1.82) | – | – | 1.08 (0.72–1.60) |
| Comorbidity | – | – | 0.96 (0.58–1.61) | – | – | 0.86 (0.54–1.38) |
Notes:
Data are presented as the hazard ratio and corresponding 95% confidence interval;
adjusted by listed variable;
disability, indicated by a Barthel Index <90;
cognitive impairment, indicated by Spanish version of the Mini-Mental State Examination <24/35;
comorbidity, measured by the Charlson Comorbidity Index (0–37).
Analyses of secondary outcomes, with mean and 95% confidence interval for groups at 24 months’ follow-up and mean difference between groups. Sample is shown for the complete follow-up period
| Mean (95% CI)
| Mean difference | ||
|---|---|---|---|
| Control | Intervention | ||
| Fractures | 0.02 (−0.18; 0.22) | 0.06 (−0.13; 0.25) | −0.03 (−0.09; −0.02) |
| Hospital emergencies | 0.46 (0.21; 0.71) | 0.47 (0.25; 0.69) | −0.01 (−0.24; 0.21) |
| Hospital admissions | 0.16 (−0.07; 0.39) | 0.19 (0.01; 0.37) | −0.03 (−0.15; 0.10) |
| Home care | 0.19 (0.12; 0.29) | 0.20 (0.14; 0.29) | −0.01 (−0.13; 0.10) |
Notes:
Proportion results;
mean difference between the control and intervention group is estimated; negative mean differences indicate a decline in the outcome measure.
Abbreviation: CI, confidence interval.
Incidence rate (95% confidence interval) of falls and follow-up durations
| Follow-up | Control | Intervention | Incidence rate | |
|---|---|---|---|---|
| 12 months | ||||
| Subjects, n | 131 | 142 | 0.56 | 0.85 (0.51–1.40) |
| 0 falls, n (%) | 98 (74.8%) | 102 (71.8%) | ||
| 1 fall, n (%) | 20 (15.3%) | 29 (20.4%) | ||
| 2 falls, n (%) | 5 (3.82%) | 6 (4.23%) | ||
| ≥3 falls, n (%) | 8 (6.11%) | 5 (3.52%) | ||
| 12–24 months | ||||
| Subjects, n | 98 | 127 | 0.08 | 2.06 (1.22–3.5) |
| 0 falls, n (%) | 71 (72.4%) | 81 (63.8%) | ||
| 1 fall, n (%) | 21 (21.4%) | 23 (18.1%) | ||
| 2 falls, n (%) | 3 (3.06%) | 13 (10.2%) | ||
| ≥3 falls, n (%) | 3 (3.06%) | 10 (7.87%) | ||
Notes:
Chi-square test between control and intervention group for number of falls;
negative binomial model adjusted by control and intervention group variable; reference category is control group.
Adherence to recommendations in the intervention group in the first and second year
| Type of recommendation | One year | Two years | ||
|---|---|---|---|---|
| Recommended n (%) | Adhered n (%) | Recommended n (%) | Adhered n (%) | |
| Discuss medication with primary care physician | 97 (65) | 63 (65) | 102 (75) | 92 (90) |
| See ophthalmologist | 88 (59) | 36 (41) | 94 (69) | 75 (80) |
| See audiologist | 59 (39) | 19 (32) | 45 (33) | 19 (42) |
| See community dietician | 135 (90) | 104 (77) | 109 (80) | 97 (89) |
| See community physical therapist | 128 (85) | 95 (74) | 88 (65) | 79 (90) |
| See community occupational therapist | 25 (17) | 13 (52) | 39 (29) | 33 (85) |
| See neurologist | 34 (23) | 19 (56) | 35 (26) | 29 (83) |
| Environmental modifications | 79 (53) | 43 (54) | 85 (63) | 65 (77) |
| See social services | 66 (44) | 33 (50) | 55 (40) | 33 (60) |
| Referred to hospital dietician service | 47 (35) | 19 (40) | ||
| Referred to hospital rehabilitation service | 59 (43) | 30 (51) | ||
Algorithm for targeted risk factors and interventions
| Risk factor | Recommendations | Baseline assessment | 3 months by telephone | 9 months by telephone | 12-month assessment |
|---|---|---|---|---|---|
| Use of ≥5 medications (over more than 6 months) | Discussion with patient about secondary effects, adherence | ||||
| If drugs | (Morinsky test) | ||||
| Anti-inflammatory | |||||
| Cardiovascular | Recommendations to discuss medication with physician; reduce usage of as-needed medication | ||||
| Antibiotics | |||||
| Benzodiazepines | |||||
| Antidepressants | |||||
| Neuroleptics | |||||
| Others (diuretics, vitamins) | Advice for nonpharmacological options for sleep, pain, and constipation | ||||
| If MNA test <23.5/30 | Provide nutrition and exercise booklet | ||||
| Problems chewing, swallowing, teething | Exercise 30 minutes before meals | ||||
| If defective mouthpiece, bad oral hygiene or not adjusted | Recommendations to physician to consider etiology | ||||
| Visual acuity: Jaeger tables <5 | Nursing accident prevention advice | ||||
| Diabetes mellitus: mydriatic camera review | Attention to turning movements ocular–cephalic | ||||
| Whispered voice test abnormal | Annual review of headphones | ||||
| Join deformity, callus | Revision of lumbar spine, and upper and lower extremities | ||||
| Tinetti gait test (<9) | Recommendations for safe performance of mobility tasks | ||||
| Hand grip dynamometry | Consider referral to physical therapy | ||||
| Barthel I ≤60/100 | Patient and caregiver education regarding safe performance task, increased supervision, or other social assistance | ||||
| MEC <24/35 | Patient and caregiver education avoiding multitasking, review of diary repercussion, consider depression | ||||
| Carpets, baths, stairs | Removal of throw rugs | ||||
| Lives alone, social risk revision | Attention to cleaning, meals, personal care, dependency | ||||
Abbreviations: MNA, Mini-Nutritional Assessment; MEC, Spanish version of Mini-Mental State Examination; ORL, otorhinolaryngologist.